A detailed history of Spreng Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Spreng Capital Management, Inc. holds 549 shares of LLY stock, worth $421,500. This represents 0.23% of its overall portfolio holdings.

Number of Shares
549
Previous 679 19.15%
Holding current value
$421,500
Previous $614,000 20.85%
% of portfolio
0.23%
Previous 0.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $100,378 - $124,802
-130 Reduced 19.15%
549 $486,000
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $20,296 - $25,453
28 Added 4.3%
679 $614,000
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $65,734 - $87,943
111 Added 20.56%
651 $506,000
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $28,255 - $38,954
65 Added 13.68%
540 $290,000
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $166,601 - $222,765
475 New
475 $222,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Spreng Capital Management, Inc. Portfolio

Follow Spreng Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spreng Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spreng Capital Management, Inc. with notifications on news.